Because SLC37A2 expression is necessary for anti-inflammatory macrophage activation in vitro and in vivo, we speculate that the impaired anti-inflammatory responses are a major driving force of enhanced atherosclerosis in the SLC37A2Δhema mice. Here, SLC37A2 is linked to atherosclerosis.